Therefore, immune cells such as conventional dendritic cells and CD16+ monocytes other than pDCs [52] could contribute to systemic IFN activity, and further investigations are needed to clarify the cellular source of high serum IFN activity in SLE. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.